Management of patients with generalised myasthenia gravis and COVID-19: four case reports

J Neurol Neurosurg Psychiatry. 2020 Oct;91(10):1124-1125. doi: 10.1136/jnnp-2020-323565. Epub 2020 Jul 10.

Authors

Annemarie Hübers¹, Agustina M Lascano², Patrice H Lalive³

Affiliations

¹ Department of Clinical Neurosciences, University Hospitals Geneva, Geneve, Switzerland annemarie.hubers@hcuge.ch.
² Division of Neurology, University Hospitals of Geneva, Geneva, Switzerland.
³ Department of Clinical Neurosciences, Division of Neurology, Unit of Neuroimmunology and Multiple Sclerosis, University Hospitals Geneva, Geneva, Switzerland.

PMID: 32651248
DOI: 10.1136/jnnp-2020-323565

No abstract available

Keywords: immunology; myasthenia; virology.

Publication types

Letter
Comment

MeSH terms

Betacoronavirus
COVID-19
Coronavirus Infections*
Humans
Lambert-Eaton Myasthenic Syndrome*
Myasthenia Gravis*
Pandemics*
Pneumonia, Viral*
SARS-CoV-2